DAMGO (TFA)
CAS No. 950492-85-0
DAMGO (TFA)( —— )
Catalog No. M30306 CAS No. 950492-85-0
DAMGO is a selective peptide agonist of the μ-opioid receptor .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | Get Quote |
|
| 10MG | 117 | Get Quote |
|
| 25MG | 251 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDAMGO (TFA)
-
NoteResearch use only, not for human use.
-
Brief DescriptionDAMGO is a selective peptide agonist of the μ-opioid receptor .
-
DescriptionDAMGO is a selective peptide agonist of the μ-opioid receptor .
-
In VitroDAMGO (1-10 μM) TFA significantly reduces the activation of neuronal Akt and ERK1/2 by CXCL12 and inhibits CXCL12-promoted neuronal survival, but does not down-regulate CXCR4 protein expression.DAMGO (1 μM) TFA effectively inhibits the prostaglandin E 2 (PGE 2) induced increase in a tetrodotoxin-resistant voltage-gated Na+ current (TTX-R I Na), i.e. PGE 2 (1 μM) can increase the TTX-R I Na peak by 103 % compared to 24.9 % with the addition of DAMGO.
-
In VivoDAMGO (i.v., 0.5-2 mg/kg) TFA can produce significant anti-injury effects on injured paws of male Sprague-Dawley rats weighing 200-225 g in a dose-dependent manner, producing an effective and long-lasting analgesic effect.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number950492-85-0
-
Formula Weight627.61
-
Molecular FormulaC28H36F3N5O8
-
Purity>98% (HPLC)
-
SolubilityH2O : 125 mg/mL (199.17 mM; Need ultrasonic)
-
SMILES——
-
Chemical NameSequence:Tyr-{d-Ala}-Gly-{Me-Phe}-Gly-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Apitegromab
Apitegromab (SRK-015) is a new myostatin inhibitor, an antibody targeting myostatin precursor, which can be used to study neuromuscular diseases including spinal muscular atrophy.
-
Hemorphin-7
Hemorphin-7 binds to the angiotensin IV receptor, triggering multiple effects including cellular proliferation and memory enhancement. Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin. Hemorphin-7 is investigated as a potential biomarker for breast cancer.
-
Eluxadoline
A potent, selective, orally bioavailable μ-opioid receptor agonist and a δ-opioid receptor antagonist for the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D).
Cart
sales@molnova.com